Norges Bank’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
Other funds holding RCUS
GS
WP
SCM
Norges Bank's RCUS Position: Q1 2025 in Review
Norges Bank sold out of Arcus Biosciences (RCUS) in Q1 2025, closing a stake of 34,044 shares — an estimated $507K sold.
Norges Bank first reported a position in RCUS in Q1 2018 and held it in 16 quarters. The position peaked at $4.02M in Q3 2022. 186 funds tracked by Wall St. Rank hold RCUS as of Q1 2025.
- Norges Bank reported no remaining Arcus Biosciences position as of Q1 2025 after selling out during the quarter.
- Norges Bank sold 34,044 Arcus Biosciences shares in Q1 2025, an estimated $507K.
- Norges Bank first reported a position in Arcus Biosciences in Q1 2018 and held it in 16 quarters.
- Norges Bank's Arcus Biosciences position peaked at $4.02M in Q3 2022.
- 186 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2025.
Based on Norges Bank's 13F filing for Q1 2025, filed 13 May 2025.